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Antiphospholipid syndrome is a systemic autoimmune disease with thrombotic tendency. Consensus guidelines for pregnancy
with antiphospholipid syndrome recommend low-dose aspirin combined with unfractionated or low-molecular-weight heparin
because antiphospholipid syndrome causes habitual abortion. We report a 36-year-old pregnant woman diagnosed with
antiphospholipid syndrome receiving anticoagulation treatment. The patient developed left abdominal pain and gross hematuria
at week 20 of pregnancy. An initial diagnosis of left ureteral calculus was made. Subsequently abdominal-pelvic computed
tomography was required for diagnosis because of the appearance of severe contralateral pain. Computed tomography revealed
serious renal hemorrhage, and ureteral stent placement and pain control by patient-controlled analgesia were required. After
treatment, continuance of pregnancy was possible and vaginal delivery was performed safely. This is the ﬁrst case report of serious
renal hemorrhage in a pregnant woman with antiphospholipid syndrome receiving anticoagulation treatment and is an instructive
case for urological and obstetrical practitioners.
1.Introduction
Antiphospholipid syndrome (APS) is a systemic autoim-
mune disease characterized by the presence of venous or
arterial thromboembolism and/or pregnancy morbidity in
association with antiphospholipid antibody (aPL). Consen-
sus guidelines for cases of pregnancy with APS without a
history of thrombosis recommend administration of low-
dose aspirin in combination with unfractionated or low-
molecular-weight heparin [1] because APS causes habitual
abortion, intrauterine growth retardation, and severe tox-
emia of pregnancy at high rates. On the other hand, renal
hemorrhage as an initial symptom of adverse events in
administrationofantiplateletandanticoagulantdrugsisvery
rare. Accordingly, it is diﬃcult to assume that antiplatelet
or anticoagulant drugs cause gross hematuria with severe
ﬂank pain. Here, we report a pregnant woman with APS
who had severe renal hemorrhage during anticoagulation
treatment.
2.CaseReport
A 36-year-old pregnant woman who had previously been
diagnosed with APS had received anticoagulation treatment
with 100mg/day of aspirin and 12000U/day of unfrac-
tionated heparin and had experienced abortion twice. She
presentedwithgrosshematuriaat20weeksofpregnancyand
discontinued aspirin administration. However, hematuria
did not resolve, and lower left abdominal pain developed.
Although hydronephrosis was not detected by ultrasound,
left ureteral calculus was suspected from the patient’s clinical
course. Seven days later, hematuria and left abdominal pain
developed again. The patient was treated conservatively
with analgesics because ultrasound and plain abdominal X-
ray results were unremarkable. Ten days later, the patient
attended the hospital emergency department and was hospi-
talized urgently in urological ward forworkup and treatment
because of severe right back pain and severe gross hematuria
developed. On admission, complete blood cell count (CBC)2 Advances in Urology
revealed elevated white blood cell counts (WBC 16.29 ×
103/µL), decreased red blood cell and hemoglobin levels
(RBC 2.76 × 106/µL and Hb 8.1g/dL), and normal platelet
counts (21.9 × 104/µL). The results of blood biochemical
andclottingtestswereunremarkable.Therewerenoﬁndings
in physical examination except for a knocking pain of right
costovertebral angle. Under an obstetrician’s instruction,
plain abdominal-pelvic computed tomography (CT) with
reduced dose was performed although the patient was in
second trimester. CT ﬁndings showed expanded right upper
urinary tract and the hematoma in the right renal pelvis
was suspected (Figures 1 and 2). There was no calculus and
no mass lesion, and perinephric bleeding was not seen. The
cause of bleeding in the right renal pelvis was unknown.
Administration of unfractionated heparin was immediately
discontinued. On day 2 after admission, severe back pain
persisted and WBC was still elevated (26.64 × 103/µL).
Therefore, antibiotic treatment was started for suspected
urinary tract infection. On day 3, patient-controlled anal-
gesia (PCA) with fentanyl was started for persistent pain
by the anesthesiologist. Blood transfusion was performed
on day 4 because CBC showed progression of anemia
(Hb 6.7g/dL). Ureteral stent placement under ultrasound
guidancewasperformedbecauseexpansionoftherightrenal
pelvis due to hematoma persisted. The pain and hematuria
were subsequently relieved. On day 16, administration of
unfractionated heparin was resumed based on consultation
with an obstetrician and a hematologist. The patient was
discharged on day 21. Although outpatient anticoagulation
treatment was continued, gross hematuria and back pain
did not recur. At 36 weeks of pregnancy, the patient was
admitted to hospital and continuous instillation of heparin
was started. One week later, she gave birth to a female
infant with a birth weight of 2190g by vaginal delivery after
discontinuation of heparin infusion. Apgar scores at 1 and
5 min were 9 and 10, respectively. Continuous instillation
of low-molecular-weight heparin was started postpartum.
Abdominal-pelvic CT and urine cytology performed on day
4 postpartum revealed no abnormalities in the urinary tract.
Heparin infusion was then switched to oral low-dose aspirin.
The ureteral stent was withdrawn on day 8, and the patient
has not developed any symptoms, such as pain or hematuria.
3. Discussion
APS is a syndrome ﬁrst described by Hughes et al. as the
anticardiolipin syndrome in 1983 [2] and is a multisystem
diseasecharacterizedbyvenousorarterialthrombosisand/or
pregnancy morbidity in association with aPL [3]. APS
causes widespread arterial and venous thrombosis, including
stroke, myocardial infarction, and deep-vein thrombosis.
PregnancymorbiditywithAPSisnotnecessarilycomplicated
by thrombosis, and habitual abortion or toxemia usually
develops as unique symptom. Aspirin and/or heparin are
usually administered as anticoagulation treatment during
pregnancy. In contrast, some cases show development of
hemorrhagic tendency, which is considered to be due to
thrombocytopenia by platelet destruction occurring with
Figure 1: Axial CT image indicating that the right renal pelvis was
ﬁlled with hematoma (arrow).
Figure 2: Longitudinal CT image indicating hematoma extending
to the lower portion of the right ureter (small arrows) and a fetus in
the uterus (large arrows).
aPL binding. An in vitro study also indicated that lupus
anticoagulant inhibits adhesion and aggregation of platelets,
and it is possible that aPL binds to platelets and reduces
platelet function [4]. In this case, because thrombocytopenia
or abnormality of clotting test was not detected throughout
theclinicalcourse,anticoagulationtreatmentwasconsidered
to be the cause of renal bleeding.
Several hemorrhagic complications have been reported,
such as subdural hematoma, ovarian hemorrhage, and
intestinal hemorrhage as the adverse events of anticoagula-
tion treatment [5] .T h e r eh a v eb e e naf e wr e p o r t so fg e n -
itourinary symptoms, such as pericapsular renal bleeding,
adrenal hemorrhage, or hemorrhagic cystitis with secondary
APS [6, 7]. Various renal complications, including renal
artery or venous thrombosis, renal infarct, hypertension,
renal failure, and various glomerular lesions, have been
reported as APS nephropathy [8]. However, to our knowl-
edge, there have been no previous reports of severe renalAdvances in Urology 3
hemorrhage with APS, and the present case was considered
very rare.
With regard to adverse eﬀects of radiation on the fetus,
it is unlikely that single pelvic CT would have teratogenic
eﬀects. However, the relative risk of carcinogenesis by
radiation exposure was reported to be 1.29 in the second
trimester (3.19 and 1.30 in ﬁrst and third trimesters,
resp.) [9]. Therefore, radiation exposure during pregnancy
should be avoided as much as possible. The patient had
symptoms on both sides, and the symptoms worsened
rapidly. Abdominal-pelvic CT was performed because it was
diﬃcult to determine her clinical condition based only on
ultrasound ﬁndings. Furthermore, various renal morbidities
should be considered in patients with APS. Although the
patient described here was in the second trimester and
the potential eﬀect on the fetus was less than in the ﬁrst
trimester, radiodiagnosis during pregnancy should always
require careful consideration.
We reported a case of renal hemorrhage in a pregnant
woman with APS. This is the ﬁrst case report of a pregnant
woman with APS developing serious renal hemorrhage. The
symptoms were relieved with ureteral stent and PCA, and
successful delivery was achieved. Administration of aspirin
and heparin is often performed in cases of pregnancy with
APS, and it is necessary to pay attention to the hemorrhagic
symptoms. In addition, diagnosis should be made as soon
as possible the symptoms emerged. However, it is diﬃcult
to carry close examinations such as contrast-enhanced CT,
magnetic resonance image, or angiography because the
patient is under a complicated condition with APS and
pregnancy. Close cooperation with related specialists should
be performed in examination and treatment of such cases.
Although to repeat examination using ultrasound is thought
as a principle method to quest the cause of severe back pain
and hematuria in pregnant patients with APS, it may be
needed to perform CT speedily with obstetrician’s instruc-
tion in case the cause of symptoms is unclear. This is an
instructive case for urological and obstetrical practitioners.
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